We are pleased to formally announce the establishment of our wholly-owned subsidiary, “Cardio IT, UAB,” which commenced operations on the 8th of September, 2023, in the city of Vilnius, Lithuania.
This significant milestone marks our inaugural entry into the European Union market. We are steadfast in our commitment and eager to initiate collaborations with esteemed medical centers and renowned research institutes as we embark on this new venture.
